Anti-Lassa Virus, Nucleoprotein [Clone 1LV15] - Purified No Carrier Protein (L350-GRP)

Lassa fever and public health impact Lassa virus is an arenavirus that causes Lassa fever, an acute viral hemorrhagic disease endemic to West Africa, with the highest burden reported in Nigeria, Sierra Leone, Liberia, and parts of Guinea. Millions of infections and thousands of deaths are estimated to occur annually, with overall infection fatality around 1–2%, but case fatality rates in hospitalized patients often ranging from 15% to over 20%, and even higher in high‑risk groups such as pregnant women.​ Human infection typically occurs through exposure to excreta of infected Mastomys rodents or via contaminated food and household environments, with increasing recognition of transmission in peri‑urban as well as rural settings. Person‑to‑person spread can occur through contact with blood or bodily fluids, leading to healthcare‑associated outbreaks and underscoring the need for rapid, reliable laboratory diagnosis.​ Clinical presentation and need for early diagnosis